Prelude Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Prelude Capital Management’s Portfolio VYNE Stock Details VYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$107K	Sell
2025 Q1	$224K	Buy
2024 Q4	$199K	Sell
2024 Q3	$122K	Buy
2024 Q2	$128K	Sell
2024 Q1	$290K	Sell
2023 Q4	$275K	Buy
2018 Q4	–	Sell
2018 Q3	$1K	Sell
2018 Q2	$16K	Buy